{{Rsnum
|rsid=17608902
|Gene=FBN2
|Chromosome=5
|position=128380874
|Orientation=plus
|GMAF=0.05693
|Gene_s=FBN2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 0.0 | 9.2 | 90.8
| HCB | 4.4 | 6.7 | 88.9
| JPT | 0.0 | 15.6 | 84.4
| YRI | 0.0 | 1.6 | 98.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 4.4 | 6.7 | 88.9
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23793025
  |Trait=Migraine - clinic-based
  |Title=Genome-wide meta-analysis identifies new susceptibility loci for migraine.
  |RiskAllele=A
  |Pval=1E-7
  |OR=1.25
  |ORtxt=[1.15-1.35]
  }}